IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 135,490,136 (75%) | — | ₹544,670 Cr |
| NII (HNI) | — | 27,098,027 (15%) | — | ₹108,934 Cr |
| Retail | — | 18,065,352 (10%) | — | ₹7,262 Cr |
| Employee | — | 391,645 (0%) | — | ₹157 Cr |
| Σ Total | — | 181,045,160 (100%) | — | ₹7,278,015 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 37 | ₹14,874 |
| Retail (Max) | 13 | 481 | ₹193,362 |
| S-HNI (Min) | 14 | 518 | ₹208,236 |
| B-HNI (Min) | 67 | 2,479 | ₹996,558 |
Financial Statements Amount in ₹ Crore
| Metric | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue | 1,946 | 7,009 | 5,610 |
| EBITDA | 337 | 971 | 672 |
| Profit After Tax | 61 | 297 | -10 |
| Net Worth | 6,177 | 6,108 | 5,642 |
| Total Assets | 10,846 | 10,471 | 9,531 |
| Reserves & Surplus | 5,855 | 5,795 | 5,467 |
| Total Borrowing | 335 | 346 | 497 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Capital expenditure towards set-up of new CoCo stores in India – 272.62
- Expenditure for lease/rent/license agreements related payments for our CoCo stores operated by the Company, in India – 591.44
- Investing in technology and cloud infrastructure – 213.38
- Brand marketing and business promotion expenses for enhancing brand awareness – 320.06
- Unidentified inorganic acquisitions and general corporate purposes –
Company Overview
Lenskart Solutions Ltd., established in 2008, is a technology-focused eyewear company involved in the design, manufacturing, branding, and retail of prescription eyeglasses, sunglasses, contact lenses, and accessories. India serves as its primary market, and as per the Redseer Report, the company recorded the highest volume of prescription eyeglasses sold in India during FY 2025.
Operating under a direct-to-consumer model, the company offers a broad range of eyewear under its own brands and sub-brands, catering to all age groups and price segments. In FY 2025, 105 new collections were launched, including collaborations with well-known brands and personalities.
As of March 31, 2025, Lenskart operated 2,723 stores globally—2,067 in India and 656 overseas—with 1,757 owned and 310 franchised stores in India. Remote eye testing is offered through 136 optometrists at 168 stores across India and select international locations, including Japan and Thailand.
Manufacturing is centralized in Bhiwadi and Gurugram, supported by regional facilities in Singapore and the UAE. This setup enables next-day delivery in 40 Indian cities and 3-day delivery in 69 cities for single-vision prescription eyewear.
The company posted revenues of ₹37,880.28 million, ₹54,277.03 million, and ₹66,525.17 million in FY 2023, 2024, and 2025 respectively, showing consistent year-on-year growth. Its apps have over 100 million cumulative downloads, with a tech team of 532 members.
Key strengths include:
- Centralized supply chain and in-house manufacturing
- In-house frame and lens engineering
- Direct-to-consumer approach
- Customer-centric product design
- Owned eyewear brand portfolio
- Technology-led operations and retail experience
- Omnichannel retail presence
- Multi-year revenue and EBITDA growth trajectory